Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | ARHGEF2 |
Upstream (Parents) |
---|
(<<) ACTB → ARHGEF2 |
(<<) ADAM15 → ARHGEF2 |
(<<) BCL2L13 → ARHGEF2 |
(<<) CYB5R3 → ARHGEF2 |
(<<) HSP90AB1 → ARHGEF2 |
(<<) JUND → ARHGEF2 |
(<<) KCTD5 → ARHGEF2 |
(<<) RXRB → ARHGEF2 |
(<<) TAGLN2 → ARHGEF2 |
(<<) TRIB1 → ARHGEF2 |
Downstream (Children) |
---|
ARHGEF2 → ADRBK1 (>>) |
ARHGEF2 → ANKRD27 (>>) |
ARHGEF2 → ATP11C (>>) |
ARHGEF2 → ATP2B1 (>>) |
ARHGEF2 → BCL2L1 (>>) |
ARHGEF2 → CALB1 (>>) |
ARHGEF2 → CASP2 (>>) |
ARHGEF2 → CDK8 (>>) |
ARHGEF2 → DKFZP434I0714 (>>) |
ARHGEF2 → EVX1 (>>) |
ARHGEF2 → EZR (>>) |
ARHGEF2 → FZD1 (>>) |
ARHGEF2 → GPR109B (>>) |
ARHGEF2 → GRK6 (>>) |
ARHGEF2 → HDAC5 (>>) |
ARHGEF2 → HIF1A (>>) |
ARHGEF2 → HIPK1 (>>) |
ARHGEF2 → HSPA9 (>>) |
ARHGEF2 → ITGB4 (>>) |
ARHGEF2 → ITPR3 (>>) |
ARHGEF2 → LOC441204 (>>) |
ARHGEF2 → MAP3K1 (>>) |
ARHGEF2 → MAP3K8 (>>) |
ARHGEF2 → MAPKAPK5 (>>) |
ARHGEF2 → MKNK1 (>>) |
ARHGEF2 → MYL5 (>>) |
ARHGEF2 → NDST1 (>>) |
ARHGEF2 → NFATC3 (>>) |
ARHGEF2 → NFKB2 (>>) |
ARHGEF2 → NLGN4Y (>>) |
ARHGEF2 → NRG1 (>>) |
ARHGEF2 → OGFR (>>) |
ARHGEF2 → PKM2 (>>) |
ARHGEF2 → PLCG1 (>>) |
ARHGEF2 → PLK1 (>>) |
ARHGEF2 → PNPLA3 (>>) |
ARHGEF2 → PTMS (>>) |
ARHGEF2 → RARG (>>) |
ARHGEF2 → RHOT1 (>>) |
ARHGEF2 → SH3GLB2 (>>) |
ARHGEF2 → SLC29A1 (>>) |
ARHGEF2 → ST3GAL1 (>>) |
ARHGEF2 → ST3GAL2 (>>) |
ARHGEF2 → STAT3 (>>) |
ARHGEF2 → STAT5B (>>) |
ARHGEF2 → STK4 (>>) |
ARHGEF2 → TP53 (>>) |